C01a2ac5 07dc 49f9 9713 90b0a2346150

2017-12-12

: Pdf C01A2Ac5-07Dc-49F9-9713-90B0A2346150 c01a2ac5-07dc-49f9-9713-90b0a2346150 12 2017 pdf

Open the PDF directly: View PDF PDF.
Page Count: 2

Presenters:
D. CHRIS METZGER, MD,
FACC, FSCAI
Director of Cardiac and Peripheral
Vascular Cath Labs
Medical Director of Clinical Research
Wellmont CVA Heart Institute
Kingsport, Tennessee
ZIAD A. ALI, MD, DPHIL
Assistant Professor of Medicine
Associate Director of Translational Medicine
Victoria and Esther Aboodi
Cardiology Researcher
Louis V Gerstner Scholar
Columbia University
Director Angiographic Core Laboratory
Cardiovascular Research Foundation
New York, New York
Provided by North American Center for Continuing
Medical Education, LLC, an HMP Company
Supported by an educational grant from
Cordis, A Cardinal Health Company.
Full Program Details at: WWW.NACCME.COM/PROGRAM/2017-811-1
Learning Objectives:
Upon completion of this activity, participants should be able to:
Identify options and risks associated with the treatment of a bifurcation lesion
Identify lesions of the side branch and the best possible treatment approach based on vessel size
Compare and contrast emerging technologies used to treat complex bifurcations
OPTIMIZING TREATMENT OF
COMPLEX
BIFURCATION
LESIONS
Approved for 1.0 AMA PRA Category 1 CreditTM and 1.0 Contact Hour for Nurses
Approved for 1 ARRT Category A CE credit by AHRA
COMPLIMENTARY CE WEBCAST
Full Program Details at: WWW.NACCME.COM/PROGRAM/2017-811-1
INTENDED LEARNERS
This activity is designed for
interventional cardiolo-
gists, vascular surgeons,
interventional radiologists,
cardiothoracic surgeons,
clinical cardiologists, nurses,
technicians, and others
involved in the treatment of
complex coronary lesions.
ACTIVITY OVERVIEW
Participants will be asked
to complete a pre-activity
survey, post-activity survey
and evaluation following the
educational session.
Individuals who participate
in the activity and submit
the evaluation form online
will immediately receive
documentation of credit.
Participants will be asked to
log in or create an account at
www.naccme.com.
Release Date: December
15, 2017
Expiration Date: December
15, 2018
Estimated time to complete:
1.0 hour
For questions regarding this
educational activity, please
call 609-371-1137.
There is no fee associated
with this activity.
ACCREDITATION
In support
of improving
patient
care, North
American Center for
Continuing Medical Education
(NACCME) is jointly accredited
by the Accreditation Council
for Continuing Medical
Education (ACCME), the
Accreditation Council for
Pharmacy Education (ACPE),
and the American Nurses
Credentialing Center (ANCC)
to provide continuing
education for the healthcare
team.
CME
NACCME designates this en-
during material for a maximum
of 1.0 AMA PRA Category 1
Credit™. Physicians should
claim only the credit commen-
surate with the extent of their
participation in the activity.
CNE
This continuing nursing
education activity awards 1.0
contact hour.
Provider approved by the
California Board of Registered
Nursing, Provider #13255 for
1.0 contact hour.
ARRT ACCREDITATION
Optimizing Treatment of
Complex Bifurcation Lesions
has been approved for 1 ARRT
Category A CE credit by The
Association for Medical Imag-
ing Management, AHRA.
AHRA is an ARRT Recognized
Continuing Education Evaluat-
ing Mechanism, (RCEEM).
Copyright © 2017 by North
American Center for Continu-
ing Medical Education, LLC
(NACCME).
Cardiovascular Learning Net-
work is a NACCME Initiative
in conjunction with
Learning Objectives:
Upon completion of this activity, participants should be able to:
Identify options and risks associated with the treatment of a bifurcation lesion
Identify lesions of the side branch and the best possible treatment approach based on vessel size
Compare and contrast emerging technologies used to treat complex bifurcations
OPTIMIZING TREATMENT OF
COMPLEX
BIFURCATION
LESIONS
Approved for 1.0 AMA PRA Category 1 CreditTM and 1.0 Contact Hour for Nurses
Approved for 1 ARRT Category A CE credit by AHRA
COMPLIMENTARY CE WEBCAST

Navigation menu